Your browser doesn't support javascript.
loading
Myeloprotective Effects of Trilaciclib Among Patients with Small Cell Lung Cancer at Increased Risk of Chemotherapy-Induced Myelosuppression: Pooled Results from Three Phase 2, Randomized, Double-Blind, Placebo-Controlled Studies.
Hussein, Maen; Maglakelidze, Marina; Richards, Donald A; Sabatini, Marielle; Gersten, Todd A; Lerro, Keith; Sinielnikov, Ivan; Spira, Alexander; Pritchett, Yili; Antal, Joyce M; Malik, Rajesh; Beck, J Thaddeus.
Afiliação
  • Hussein M; Florida Cancer Specialists, Leesburg, FL, USA.
  • Maglakelidze M; LLC Arensia Exploratory Medicine, Tbilisi, Georgia.
  • Richards DA; Texas Oncology-Tyler, US Oncology Research, Tyler, TX, USA.
  • Sabatini M; Saint Leon Hospital, Bayonne, France.
  • Gersten TA; Florida Cancer Specialists, West Palm Beach, FL, USA.
  • Lerro K; Regional Medical Oncology Center, Wilson, NC, USA.
  • Sinielnikov I; Volyn Regional Oncology Center, Lutsk, Ukraine.
  • Spira A; Virginia Cancer Specialists, Fairfax, VA, USA.
  • Pritchett Y; US Oncology Research, The Woodlands, TX, USA.
  • Antal JM; G1 Therapeutics, Inc., Research Triangle Park, NC, USA.
  • Malik R; G1 Therapeutics, Inc., Research Triangle Park, NC, USA.
  • Beck JT; G1 Therapeutics, Inc., Research Triangle Park, NC, USA.
Cancer Manag Res ; 13: 6207-6218, 2021.
Article em En | MEDLINE | ID: mdl-34408488
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article